RxDoctor Payments Data

Joseph Liu, MD

Sports Medicine · Pomona, CANPI 1154689248

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Innocoll Pharmaceuticals Limited at 37.2% of the total. Reporting peaked in 2022 at $6,828 and has fallen 67.4% since, to $2,228 in 2025.

$18,578in general payments, 2019–2025

Across 160 payments — averaging $116.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Innocoll Pharmaceuticals Limited$7K
  • Stryker$4K
  • Smith+Nephew$3K
  • Empire Medical, Inc$1K
  • Zimmer Biomet$894
  • Abanza Inc.$627
  • plus $2K from 15 others
$55,290in research payments, 2019–2025

Across 11 payments — averaging $5026.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$50K
  • Anika Therapeutics, Inc.$5K

What the payments were for

  • Consulting fees$2,60014%
  • Speaking & faculty fees$1,92510%
  • Travel & lodging$5,70131%
  • Food & beverage$7,11338%
  • Education$1,2397%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Innocoll Pharmaceuticals Limited6$6,906
Stryker70$4,127
Smith+Nephew26$3,154
Empire Medical, Inc1$1,200
Zimmer Biomet31$894
Abanza Inc.5$627
Arcuro Medical Inc1$508
US Implant Solutions, LLC1$219
Merz North America, Inc.3$197
Trice Medical, Inc.3$148
Bone Support Inc.1$132
Sportstek Medical, Inc1$121
Ossio Inc1$115
Johnson & Johnson3$81
Moximed, Inc1$38
Globus Medical1$22
Pacira Therapeutics, Inc.1$22
Vericel Corporation1$21
Trevena, Inc.1$17
Neurocrine Biosciences, Inc.1$16
Anika Therapeutics, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,578 in reported general payments places this provider in the 75th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California →

Medicare billing

Part B allowed, 2024
$31,381
Medicare patients
93
Services billed
426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Pomona

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →